Literature DB >> 1648652

Site-specific water proton relaxation enhancement of iron(III) chelates noncovalently bound to human serum albumin.

B G Jenkins1, E Armstrong, R B Lauffer.   

Abstract

Binding of potential blood pool and hepatobiliary paramagnetic iron(III) contrast agents, rac- and meso-Fe(5-Br-EHPG)- (iron(III) N,N'-ethylenebis [(5-bromo-2-hydroxyphenyl)glycinate]) and Fe(5-Br-HBED)- (iron(III) N,N'-bis-(5-bromo-2-hydroxybenzyl)ethylenediaminediacetic acid) to human serum albumin (HSA) has been studied using the proton relaxation enhancement (PRE) effect on solvent protons. These chelates bind avidly to multiple sites on HSA with binding constants on the order of 10(4) to 10(5) M-1. Interestingly, binding results in a decrease in the diamagnetic component of the water relaxivity due to HSA, while the expected enhancement of the paramagnetic component of water proton relaxation rates occurs due to the increase in the rotational correlation times of the protein-bound agents. These relaxation enhancements are variable, depending upon the site on the protein to which these chelates are bound, and can be as high as approximately 7 mM-1 s-1 at 5 degrees C and approximately 5 mM-1 s-1 at 37 degrees C at 20 MHz (enhancements of approximately 2-5). Change of temperature from 5 to 37 degrees C also appears to switch the relative affinities of these chelates for their primary and secondary binding sites. It is found that the important HSA binding site for the heme breakdown product, bilirubin-IX alpha, is a target for these agents and is the site of highest relaxivity for all the agents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648652     DOI: 10.1002/mrm.1910170120

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  6 in total

1.  Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging.

Authors:  Yin-Ching I Chen; Ji-Kyung Choi; Susan L Andersen; Bruce R Rosen; Bruce G Jenkins
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

2.  Structural Features of Europium(II)-Containing Cryptates That Influence Relaxivity.

Authors:  Chamika U Lenora; Fabio Carniato; Yimin Shen; Zahid Latif; E Mark Haacke; Philip D Martin; Mauro Botta; Matthew J Allen
Journal:  Chemistry       Date:  2017-08-22       Impact factor: 5.236

3.  Cytotoxicity of a Ti(IV) compound is independent of serum proteins.

Authors:  Arthur D Tinoco; Horatio R Thomas; Christopher D Incarvito; Alan Saghatelian; Ann M Valentine
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

4.  High-relaxivity magnetic resonance imaging contrast agents. Part 2. Optimization of inner- and second-sphere relaxivity.

Authors:  Vincent Jacques; Stéphane Dumas; Wei-Chuan Sun; Jeffrey S Troughton; Matthew T Greenfield; Peter Caravan
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

5.  Exploring titanium(IV) chemical proximity to iron(III) to elucidate a function for Ti(IV) in the human body.

Authors:  Manoj Saxena; Sergio A Loza-Rosas; Kavita Gaur; Shweta Sharma; Sofia C Pérez Otero; Arthur D Tinoco
Journal:  Coord Chem Rev       Date:  2018-03-20       Impact factor: 22.315

Review 6.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.